Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Bio Rad Laboratories Inc before investing.

In this article, we go over a few key elements for understanding Bio Rad Laboratories Inc’s stock price such as:

• Bio Rad Laboratories Inc’s current stock price and volume
• Why Bio Rad Laboratories Inc’s stock price changed recently
• Upgrades and downgrades for BIO from analysts
• BIO’s stock price momentum as measured by its relative strength

About Bio Rad Laboratories Inc (BIO)

Before we jump into Bio Rad Laboratories Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Want to learn more about Bio Rad Laboratories Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Bio Rad Laboratories Inc.

Bio Rad Laboratories Inc’s Stock Price as of Market Close

As of September 26, 2024, 4:00 PM, CST, Bio Rad Laboratories Inc’s stock price was $332.10.

Bio Rad Laboratories Inc is up 5.24% from its previous closing price of $315.55.

During the last market session, Bio Rad Laboratories Inc’s stock traded between $315.31 and $329.96. Currently, there are 28.40 million shares of Bio Rad Laboratories Inc stock available for purchase.

Unfortunately, Bio Rad Laboratories Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Bio Rad Laboratories Inc Stock Price History

Bio Rad Laboratories Inc’s (BIO) price is currently down 1.55% so far this month.

During the month of September, Bio Rad Laboratories Inc’s stock price has reached a high of $347.70 and a low of $311.04.

Over the last year, Bio Rad Laboratories Inc has hit prices as high as $366.30 and as low as $261.59. Year to date, Bio Rad Laboratories Inc’s stock is down 21.02%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Bio Rad Laboratories Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 25, 2024, there was 1 analyst who downgraded Bio Rad Laboratories Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Bio Rad Laboratories Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Bio Rad Laboratories Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Bio Rad Laboratories Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Bio Rad Laboratories Inc (BIO) by visiting AAII Stock Evaluator.

Relative Price Strength of Bio Rad Laboratories Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 25, 2024, Bio Rad Laboratories Inc has a weighted four-quarter relative price strength of -4.39%, which translates to a Momentum Score of 47 and is considered to be Average.

Want to learn more about how Bio Rad Laboratories Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Bio Rad Laboratories Inc Stock Price: Bottom Line

As of September 26, 2024, Bio Rad Laboratories Inc’s stock price is $332.10, which is up 5.24% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Bio Rad Laboratories Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.